Porin Deficiency in Carbapenem-Resistant Enterobacter aerogenes Strains. 2018

Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
1 Institute of Antibiotics, Huashan Hospital, Fudan University , Shanghai, People's Republic of China .

OBJECTIVE The more frequent reports of carbapenem-resistant Enterobacteriaceae have raised the alarm for public health. Apart from the production of carbapenemases, deficiency (decreased or loss of expression) of outer membrane proteins (OMPs) has been proposed as a potentially important mechanism of carbapenem resistance. The aim of the present study was to evaluate the contribution of the major OMPs to carbapenem resistance in Enterobacter aerogenes (CREA) isolates and also investigate the role of small RNAs (sRNAs) in inducing porin-associated permeability defects. METHODS The differential expression of OMPs was analyzed in four clinical CREA isolates. omp35 and omp36 genes were further investigated by whole-genome sequencing, induction of meropenem resistance, sRNA overexpression, OMP complementation assays, and reverse transcription-quantitative PCR. RESULTS All four isolates examined were deficient in omp35 and omp36. Functional restoration of these two genes confirmed their contribution to carbapenem resistance. The meropenem induction assay further revealed that porin deficiency plays a role in carbapenem resistance under antibiotic selection pressure. Single-point mutations in omp36 leading to premature stop codons were detected in two of the isolates. Elevated expression levels of the sRNAs micF and micC were detected in the other two porin-deficient isolates, which were predicted to be potential porin regulators from whole-genome sequencing. Overexpression of micF and micC downregulated the expression of Omp35 and Omp36, respectively. CONCLUSIONS Porin deficiency plays an important role in carbapenem resistance among clinical E. aerogenes isolates under regulation of the sRNAs micC and micF. Furthermore, overexpression of micC and micF had a minor to no impact on carbapenem minimum inhibitory concentrations, and thus, the regulatory mechanism is likely to be complex.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073182 Carbapenem-Resistant Enterobacteriaceae Strains of Enterobacteriaceae that are resistant to CARBAPENEMS, primarily due to the acquisition of carbapenemase (BETA-LACTAMASE) genes. Carbapenemase-Producing Enterobacteriaceae
D000073336 Whole Genome Sequencing Techniques to determine the entire sequence of the GENOME of an organism or individual. Complete Genome Sequencing,Genome Sequencing, Complete,Genome Sequencing, Whole,Sequencing, Complete Genome,Sequencing, Whole Genome
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001425 Bacterial Outer Membrane Proteins Proteins isolated from the outer membrane of Gram-negative bacteria. OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor

Related Publications

Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
December 1996, Antimicrobial agents and chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
May 2002, Biochemical and biophysical research communications,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
August 2020, Antimicrobial agents and chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
March 2004, Antimicrobial agents and chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
December 2002, Antimicrobial agents and chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
January 1991, Chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
December 1999, Biochemical and biophysical research communications,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
June 2004, Antimicrobial agents and chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
April 2005, Antimicrobial agents and chemotherapy,
Min Hao, and Meiping Ye, and Zhen Shen, and Fupin Hu, and Yang Yang, and Shi Wu, and Xiaogang Xu, and Sihui Zhu, and Xiaohua Qin, and Minggui Wang
August 2004, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!